Literature DB >> 32078361

Initial Precipitants and Recurrence of Atrial Fibrillation.

Elizabeth Y Wang1,2, Olivia L Hulme1, Shaan Khurshid1,3,4, Lu-Chen Weng1,4, Seung Hoan Choi4, Allan J Walkey5, Jeffrey M Ashburner6,7, David D McManus8, Daniel E Singer6,7, Steven J Atlas6,7, Emelia J Benjamin9,10,11, Patrick T Ellinor1,4, Ludovic Trinquart12, Steven A Lubitz3,4.   

Abstract

BACKGROUND: Atrial fibrillation (AF) may occur after an acute precipitant and subsequently resolve. Management guidelines for AF in these settings are unclear as the risk of recurrent AF and related morbidity is poorly understood. We examined the relations between acute precipitants of AF and long-term recurrence of AF in a clinical setting.
METHODS: From a multi-institutional longitudinal electronic medical record database, we identified patients with newly diagnosed AF between 2000 and 2014. We developed algorithms to identify acute AF precipitants (surgery, sepsis, pneumonia, pneumothorax, respiratory failure, myocardial infarction, thyrotoxicosis, alcohol, pericarditis, pulmonary embolism, and myocarditis). We assessed risks of AF recurrence in individuals with and without a precipitant and the relations between AF recurrence and heart failure, stroke, and mortality.
RESULTS: Among 10 723 patients with newly diagnosed AF (67.9±9.9 years, 41% women), 19% had an acute AF precipitant, the most common of which were cardiac surgery (22%), pneumonia (20%), and noncardiothoracic surgery (15%). The cumulative incidence of AF recurrence at 5 years was 41% among individuals with a precipitant compared with 52% in those without a precipitant (adjusted hazard ratio [HR], 0.75 [95% CI, 0.69-0.81]; P<0.001). The lowest risk of recurrence among those with precipitants occurred with postoperative AF (5-year incidence 32% in cardiac surgery and 39% in noncardiothoracic surgery). Regardless of the presence of an initial precipitant, recurrent AF was associated with increased adjusted risks of heart failure (hazard ratio, 2.74 [95% CI, 2.39-3.15]; P<0.001), stroke (hazard ratio, 1.57 [95% CI, 1.30-1.90]; P<0.001), and mortality (hazard ratio, 2.96 [95% CI, 2.70-3.24]; P<0.001).
CONCLUSIONS: AF after an acute precipitant frequently recurs, although the risk of recurrence is lower than among individuals without an acute precipitant. Recurrence is associated with substantial long-term morbidity and mortality. Future studies should address surveillance and management after newly diagnosed AF in the setting of an acute precipitant.

Entities:  

Keywords:  atrial fibrillation; heart failure; mortality; risk factor; stroke

Mesh:

Year:  2020        PMID: 32078361      PMCID: PMC7141776          DOI: 10.1161/CIRCEP.119.007716

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  35 in total

1.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; Davis S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Huezey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094

2.  Pericarditis-associated atrial fibrillation.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2015-05-29       Impact factor: 5.994

3.  New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft.

Authors:  Mikhael F El-Chami; Patrick Kilgo; Vinod Thourani; Omar M Lattouf; David B Delurgio; Robert A Guyton; Angel R Leon; John D Puskas
Journal:  J Am Coll Cardiol       Date:  2010-03-30       Impact factor: 24.094

4.  Relation of recurrence of atrial fibrillation after non-ST-elevation acute myocardial infarction to left atrial abnormality.

Authors:  Vignendra Ariyarajah; Maciej Malinski; Aliasghar Khadem; Robert Harizi; Kevin Wolfe; David H Spodick
Journal:  Am J Cardiol       Date:  2007-11-13       Impact factor: 2.778

5.  Incidence, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery.

Authors:  Marjorie Funk; Sally B Richards; Jill Desjardins; Christy Bebon; Heather Wilcox
Journal:  Am J Crit Care       Date:  2003-09       Impact factor: 2.228

Review 6.  Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.

Authors:  Joern Schmitt; Gabor Duray; Bernard J Gersh; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

7.  New onset postoperative atrial fibrillation is associated with a long-term risk for stroke and death following cardiac surgery.

Authors:  Peter Horwich; Karen J Buth; Jean-Francois Légaré
Journal:  J Card Surg       Date:  2012-11-27       Impact factor: 1.620

8.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).

Authors:  Christina Magnussen; Teemu J Niiranen; Francisco M Ojeda; Francesco Gianfagna; Stefan Blankenberg; Inger Njølstad; Erkki Vartiainen; Susana Sans; Gerard Pasterkamp; Maria Hughes; Simona Costanzo; Maria Benedetta Donati; Pekka Jousilahti; Allan Linneberg; Tarja Palosaari; Giovanni de Gaetano; Martin Bobak; Hester M den Ruijter; Ellisiv Mathiesen; Torben Jørgensen; Stefan Söderberg; Kari Kuulasmaa; Tanja Zeller; Licia Iacoviello; Veikko Salomaa; Renate B Schnabel
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

9.  A Simple and Portable Algorithm for Identifying Atrial Fibrillation in the Electronic Medical Record.

Authors:  Shaan Khurshid; John Keaney; Patrick T Ellinor; Steven A Lubitz
Journal:  Am J Cardiol       Date:  2015-11-06       Impact factor: 2.778

10.  Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study.

Authors:  Steven A Lubitz; Xiaoyan Yin; Michiel Rienstra; Renate B Schnabel; Allan J Walkey; Jared W Magnani; Faisal Rahman; David D McManus; Thomas M Tadros; Daniel Levy; Ramachandran S Vasan; Martin G Larson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2015-03-13       Impact factor: 29.690

View more
  10 in total

1.  Is glucose metabolism in the atria in patients with atrial fibrillation due to inflammation or remodeling?

Authors:  Ayaz Aghayev
Journal:  J Nucl Cardiol       Date:  2022-01-12       Impact factor: 5.952

2.  ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.

Authors:  Shaan Khurshid; Samuel Friedman; Christopher Reeder; Paolo Di Achille; Nathaniel Diamant; Pulkit Singh; Lia X Harrington; Xin Wang; Mostafa A Al-Alusi; Gopal Sarma; Andrea S Foulkes; Patrick T Ellinor; Christopher D Anderson; Jennifer E Ho; Anthony A Philippakis; Puneet Batra; Steven A Lubitz
Journal:  Circulation       Date:  2021-11-08       Impact factor: 29.690

3.  High-Sensitivity Estimate of the Incidence of New-Onset Atrial Fibrillation in Critically Ill Patients.

Authors:  William F McIntyre; Emilie P Belley-Côté; Maria E Vadakken; Anand S Rai; Alexandra P Lengyel; Bram Rochwerg; Akash K Bhatnagar; Bishoy Deif; Kevin J Um; Jessica Spence; Stuart J Connolly; Shrikant I Bangdiwala; Purnima Rao-Melacini; Jeff S Healey; Richard P Whitlock
Journal:  Crit Care Explor       Date:  2021-01-08

4.  Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy.

Authors:  Darae Ko; Connor Saleeba; Hammad Sadiq; Sybil Crawford; Tenes Paul; Qiming Shi; Ziyue Wang; Emelia J Benjamin; Allan J Walkey; Steven A Lubitz; Alok Kapoor; David McManus
Journal:  J Am Heart Assoc       Date:  2021-10-20       Impact factor: 5.501

Review 5.  Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?

Authors:  Isuru Induruwa; Eleanor Hennebry; James Hennebry; Mrinal Thakur; Elizabeth A Warburton; Kayvan Khadjooi
Journal:  Eur J Intern Med       Date:  2021-11-09       Impact factor: 4.487

6.  Cohort design and natural language processing to reduce bias in electronic health records research.

Authors:  Shaan Khurshid; Christopher Reeder; Lia X Harrington; Pulkit Singh; Gopal Sarma; Samuel F Friedman; Paolo Di Achille; Nathaniel Diamant; Jonathan W Cunningham; Ashby C Turner; Emily S Lau; Julian S Haimovich; Mostafa A Al-Alusi; Xin Wang; Marcus D R Klarqvist; Jeffrey M Ashburner; Christian Diedrich; Mercedeh Ghadessi; Johanna Mielke; Hanna M Eilken; Alice McElhinney; Andrea Derix; Steven J Atlas; Patrick T Ellinor; Anthony A Philippakis; Christopher D Anderson; Jennifer E Ho; Puneet Batra; Steven A Lubitz
Journal:  NPJ Digit Med       Date:  2022-04-08

7.  Tamsulosin-Induced Atrial Fibrillation With Rapid Ventricular Response.

Authors:  Duncan McGuire; Heaveen Ahdi; Nicholas Mielke; Amit Bahl
Journal:  Cureus       Date:  2022-06-07

8.  Prediction performance and fairness heterogeneity in cardiovascular risk models.

Authors:  Uri Kartoun; Shaan Khurshid; Bum Chul Kwon; Aniruddh P Patel; Puneet Batra; Anthony Philippakis; Amit V Khera; Patrick T Ellinor; Steven A Lubitz; Kenney Ng
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

9.  COVID-19 and stroke, a case series and review of literature.

Authors:  Hisham Elkhider; Faisal Ibrahim; Rohan Sharma; Sen Sheng; Madhu Jasti; Mitesh Lotia; Nidhi Kapoor; Sanjeeva Onteddu; Sajjad Mueed; Hesham Allam; Krishna Nalleballe
Journal:  Brain Behav Immun Health       Date:  2020-11-04

10.  The contribution of intermittent handheld electrocardiogram and continuous electrocardiogram monitoring with an implantable loop recorder to detect incident and recurrent atrial fibrillation during 1 year after coronary artery bypass graft surgery: A prospective cohort study.

Authors:  Emma Sandgren; Anders Wickbom; Torbjörn Kalm; Anders Ahlsson; Nils Edvardsson; Johan Engdahl
Journal:  Heart Rhythm O2       Date:  2021-05-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.